Coadministration of erlotinib and curcumin augmentatively reduces cell viability in lung cancer cells. (Q39110498)
Jump to navigation
Jump to search
scientific article published on 13 August 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Coadministration of erlotinib and curcumin augmentatively reduces cell viability in lung cancer cells. |
scientific article published on 13 August 2013 |
Statements
Coadministration of erlotinib and curcumin augmentatively reduces cell viability in lung cancer cells (English)
Yotaro Izumi
Jun Yamamoto
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference